Price:
Rs. 14,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: C8769
Frequently Asked Questions (FAQ's):
What does the CLL MRD by Flow Cytometer test include?
This test detects and quantifies minimal residual leukemic cells in blood to monitor disease status and treatment effectiveness.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses multi-color flow cytometry with validated protocols and antibody panels to accurately identify residual CLL cells in EDTA blood.
Who should take this test?
Patients diagnosed with chronic lymphocytic leukemia undergoing therapy or in remission may be advised to monitor MRD for treatment evaluation.
What sample type is required?
An EDTA anticoagulated blood sample is needed to maintain viable lymphocytes for precise flow cytometric analysis.
Why is MRD monitoring important in CLL?
Measuring minimal residual disease helps determine treatment response, predict relapse risk, and guide ongoing therapeutic decisions.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated flow cytometry protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation is required; patients should provide the sample according to physician instructions.
How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides timely reports to support clinical decision-making and follow-up care.